NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.14%73.7914.4%$580.89m
AMGNAmgen Inc.
-0.15%191.781.2%$564.22m
GILDGilead Sciences, Inc.
0.50%65.900.9%$533.03m
CELGCelgene Corporation
0.83%68.771.2%$524.61m
BIIBBiogen Inc.
1.15%318.181.3%$363.55m
ILMNIllumina, Inc.
-2.82%317.263.5%$340.28m
REGNRegeneron Pharmaceuticals, Inc.
-0.18%380.482.6%$272.62m
VRTXVertex Pharmaceuticals Incorporated
-0.74%168.811.9%$224.80m
AAgilent Technologies, Inc.
-0.82%68.791.5%$223.65m
ALXNAlexion Pharmaceuticals, Inc.
2.92%112.622.0%$150.89m
INCYIncyte Corporation
-0.29%66.062.5%$97.48m
EXASExact Sciences Corporation
-0.40%68.0425.3%$93.02m
SRPTSarepta Therapeutics, Inc.
-3.02%115.9115.4%$88.03m
BLUEBluebird Bio, Inc.
2.56%106.0414.4%$82.36m
NKTRNektar Therapeutics
-3.48%35.245.5%$81.15m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on July 25, 2000 and is headquartered in Shelton, CT.